Patents
Patents for C07D 261 - Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings (11,459)
10/2012
10/31/2012CN101454297B Aryl-4-ethynyl-isoxazole derivatives
10/31/2012CN101389614B Process for production of 3-{5-[4-(cyclopentyloxy)-2-hydroxybenzoyl]-2-[(3-hydroxy-1,2-benzisoxazol-6-yl)methoxy]phenyl}propionate ester and intermediate for the process
10/31/2012CN101142198B Isoxazole combretastatin derivatives for the treatment of disorders
10/30/2012US8299257 Compounds which have activity at M1receptor and their uses in medicine
10/30/2012US8299243 Indazole, benzisoxazole, and benzisothiazole kinase inhibitors
10/30/2012US8299103 Compounds which selectively modulate the CB2 receptor
10/26/2012WO2012142671A1 Aromatic amides and uses thereof
10/25/2012US20120271055 Aryl compounds as ppar ligands and their use
10/25/2012US20120270780 Method and composition for modulating erythropoiesis
10/23/2012US8293920 Synthesis of enone intermediate
10/23/2012US8293765 Injectable depot formulation comprising crystals of iloperidone
10/23/2012US8293738 Indazole inhibitors of kinase
10/18/2012WO2012102560A3 Novel 4-0-methylhonokiol derivative and composition containing same as active ingredient for treatment of inflammatory diseases
10/18/2012US20120264947 Method for Producing 5,5-Disubstituted 4,5-Dihydroisoxazol-3-Thiocarboxamidine Salts
10/17/2012EP2509638A1 Iodine radiolabelling method
10/16/2012US8288560 Derivatives of heterocycles with 5 members, their preparation and their use as medicaments
10/16/2012US8288393 Nitrogen-containing heterocyclic compound and pest control agent
10/16/2012US8288371 Ortho pyrrolidine, benzyl-substituted heterocycle CCR1 antagonists for autoimmune diseases and inflammation
10/11/2012WO2012137094A1 Isoxazole derivatives useful as antibacterial agents
10/11/2012WO2012136120A1 Aryl acrylamide compound and use thereof in preparing immunosuppressant
10/11/2012WO2011119732A3 Method for integrin ligand discovery
10/11/2012CA2830920A1 Isoxazole derivatives useful as antibacterial agents
10/10/2012CN102718703A Dimethyl-containing arylurea derivative with dual GK/PPAR agonist activities
10/10/2012CN102225914B 3-alkenyl-4-aldehyde-5-aryl-4-isoxazoline compound, preparation method thereof and purpose thereof
10/10/2012CN101450934B Sulfonyl-derivatives as novel inhibitors of histone deacetylase
10/04/2012WO2012130798A1 Herbicidally and fungicidally active 3-phneylisoxazoline-5-carboxamides and 3-phneylisoxazoline-5-thioamides
10/04/2012US20120252799 Heterocyclic aromatic compounds useful as growth hormone secretagogues
10/04/2012US20120252797 Isoxazole Compounds As Inhibitors Of Heat Shock Proteins
10/04/2012US20120252792 Methods and compositions for modulating rho-mediated gene transcription
10/04/2012CA2831704A1 Herbicidally and fungicidally active 3-phneylisoxazoline-5-carboxamides and 3-phneylisoxazoline-5-thioamides
10/03/2012EP2504322A1 Method for producing 5,5-disubstituted 4,5-dihydroisoxazol-3-thiocarboxamidine salts
10/03/2012EP2504321A1 Method for producing 5,5-disubstituted 2-isoxazolines
10/03/2012CN102712603A Radioiodination method
10/03/2012CN102702045A Benzoylpyrazole compound and herbicide comprising the same
10/03/2012CN101500986B Di-aromatic substituted amides as inhibitors for GLYT1
10/03/2012CN101460453B Novel sulfonamide compounds
10/03/2012CN101351456B Isoxazolines for controlling invertebrate pests
09/2012
09/27/2012WO2012127347A1 Isoxazoline derivatives as antiparasitic agents
09/27/2012WO2012047907A9 Synthesis of c5-substituted tetracyclines, uses thereof, and intermediates thereto
09/27/2012WO2012031298A3 Ethynylbenzene derivatives
09/27/2012CA2829179A1 Isoxazoline derivatives as antiparasitic agents
09/26/2012EP2501683A1 Substituted carbamoylmethylamino acetic acid derivatives as novel nep inhibitors
09/26/2012CN102695699A Aminopropenoates as fungicides
09/26/2012CN102690241A Benzoyl urea compound containing isoxazoline and isoxazole structure, and preparation and application thereof
09/25/2012CA2667481C New phenylsulfamoyl benzamide derivatives as bradykinin antagonists
09/25/2012CA2530983C Compounds, methods and formulations for the oral delivery of a glucagon like peptide (glp)-1 compound or an melanocortin 4 receptor (mc4) agonist peptide
09/20/2012US20120238760 Method for Producing 5,5-Disubstituted 2-Isoxazolines
09/20/2012US20120238578 Compositions useful as inhibitors of voltage-gated sodium channels
09/20/2012US20120238517 Insecticidal compounds based on isoazoline derivatives
09/19/2012CN102686571A Tricyclic heterocyclic compounds
09/19/2012CN101389352B Agent for treating or preventing digestive ulcer
09/18/2012US8269017 Compounds for the treatment of proliferative disorders
09/13/2012US20120232116 Novel fxr (nr1h4) binding and activity modulating compounds
09/12/2012CN102666504A Compounds as lysophosphatidic acid receptor antagonists
09/12/2012CN102666503A Method for producing 5,5-disubstituted 2-isoxazolines
09/12/2012CN102666502A Method for producing 5,5-disubstituted 4,5-dihydroisoxazol-3-thiocarboxamidine salts
09/12/2012CN102666493A Substituted carbamoylmethylamino acetic acid derivatives as novel NEP inhibitors
09/12/2012CN102659705A Synthetic method of 3,4-disubstituted isoxazole compound
09/11/2012US8263634 Heteroaryl-ureas and their use as glucokinase activators
09/11/2012US8263629 Substituted aminobutyric derivatives as neprilysin inhibitors
09/07/2012WO2012119079A1 uPAR-uPA INTERACTION INHIBITORS AND METHODS FOR TREATING CANCER
09/05/2012EP2495238A1 Novel 3-hydroxy-5-arylisoxazole derivative
09/05/2012EP2493866A1 Tricyclic heterocyclic compounds
09/05/2012EP2493855A1 (1,1, 1,3, 3, 3-hexafluoro-2-hydroxypropan-2-yl) phenyl derivatives, pharmaceutical compositions thereof and their use for the treatment of atherosclerosis
09/05/2012CN1842521B Caspase inhibitors containing isoxazoline ring
09/05/2012CN102656168A Polycyclic compounds as lysophosphatidic acid receptor antagonists
09/04/2012US8258162 Catechol derivative, pharmaceutical composition containing the same, use of the catechol derivative, and use of the pharmaceutical composition
08/2012
08/30/2012US20120220776 Process for the preparation of iloperidone using a novel intermediate
08/30/2012US20120220772 Novel 3-hydroxy-5-arylisoxazole derivative
08/30/2012US20120220769 PROCESS FOR PREPARING A 2-ALKYNYL SUBSTITUTED 5-AMINO-PYRAZOLO-[4,3-e]-1,2,4-TRIAZOLO[1,5-c]PYRIMIDINE
08/28/2012US8252797 Heterocyclic compounds as adenosine receptor antagonist
08/28/2012CA2415718C 7-substituted tetracycline compounds
08/23/2012WO2012112742A1 Substituted aminobutyric derivatives as neprilysin inhibitors
08/23/2012US20120214769 Novel Antagonists of the Glucagon Receptor
08/23/2012US20120213807 Neprilysin inhibitors
08/23/2012US20120213806 Neprilysin inhibitors
08/23/2012CA2825737A1 Substituted aminobutyric derivatives as neprilysin inhibitors
08/22/2012EP2489350A1 N-hydroxylsulfonamide derivatives as new physiologically useful nitroxyl donors
08/22/2012EP2488496A1 Aminopropenoates as fungicides
08/22/2012EP1611112B1 Isoxazole compounds as inhibitors of heat shock proteins
08/22/2012CN102643244A 5-aryl isoxazolines for controlling invertebrate pests
08/21/2012US8247455 Guanylhydrazone compounds, compositions, methods of making and using
08/21/2012CA2509086C Substituted arylcyclopropylacetamides as glucokinase activators
08/21/2012CA2479877C Substituted tetracycline compounds
08/16/2012WO2012108478A1 Monocyclic compound
08/16/2012WO2012107850A1 Glucagon receptor modulator
08/16/2012CA2825102A1 Glucagon receptor modulators
08/15/2012EP2487160A1 Synthesis of Enone Intermediate
08/15/2012EP2044004B1 Benzamide derivatives as modulators of 11beta-hsd1 for treating diabetes and obesity
08/15/2012CN102639515A Compounds as lysophosphatidic acid receptor antagonists
08/14/2012US8242283 Isoxazoline compound and pesticide
08/09/2012US20120203102 Azulene and azaazulene systems for imaging, monitoring and therapy
08/09/2012US20120202834 Glucagon receptor modulators
08/09/2012US20120202786 Therapeutic isoxazole compounds
08/09/2012US20120202777 C-Linked Hydroxamic Acid Derivatives Useful As Antibacterial Agents
08/09/2012US20120202750 Inhibitors of iap
08/08/2012EP2483269A2 Polycyclic compounds as lysophosphatidic acid receptor antagonists
08/08/2012EP2483254A1 Novel compounds
08/08/2012EP2483253A2 Compounds as lysophosphatidic acid receptor antagonists
08/08/2012EP2483252A2 Compounds as lysophosphatidic acid receptor antagonists
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 ... 115